Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bellina

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal D'Urologie|January 1, 1987
[Use of the monoclonal antibody KI-67 in the study of the proliferative activity of urologic tumors. Preliminary data]D Fontana, M Bellina, G Valente, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 28, 2001
[Pelvic ultrasound monitoring of lymphocele in patients treated with radical prostatectomy]F Porpiglia, M Bellina, R Tarabuzzi, et al.
Epidemiology and Psychiatric Sciences|July 17, 2012
Psychopathology and adversities from early- to late-adolescence: a general population follow-up study with the CBCL DSM-Oriented ScalesM Nobile, P Colombo, M Bellina, et al.
Archivio Italiano Di Urologia, Nefrologia, Andrologia : Organo Ufficiale Dell'Associazione Per La Ricerca in Urologia = Urological, Nephrological, and Andrological Sciences|June 1, 1991
[Reliability of transrectal echography in the early diagnosis of prostatic carcinoma: our experience]D Fontana, F Porpiglia, G Fasolis, et al.
European Urology|January 1, 1996
Evaluation of c-ras oncogene product (p21) in superficial bladder cancerD Fontana, M Bellina, C Scoffone, et al.
Urology|April 10, 2004
Y-neobladder: an easy, fast, and reliable procedureD Fontana, M Bellina, G Fasolis, et al.
Progress in Clinical and Biological Research|January 1, 1987
Results of long term treatment of advanced prostatic cancer with the LHRH analogue buserelinD Fontana, D F Randone, G C Isaia, et al.
Cancer|June 22, 2000
Circulating neuroendocrine markers in patients with prostate carcinomaA Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology|October 1, 1992
Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinomaD Fontana, M Bellina, L Gubetta, et al.
The Journal of Urology|September 19, 2000
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baselineA Berruti, L Dogliotti, R Bitossi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal D'Urologie|January 1, 1987
[Use of the monoclonal antibody KI-67 in the study of the proliferative activity of urologic tumors. Preliminary data]D Fontana, M Bellina, G Valente, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 28, 2001
[Pelvic ultrasound monitoring of lymphocele in patients treated with radical prostatectomy]F Porpiglia, M Bellina, R Tarabuzzi, et al.
Epidemiology and Psychiatric Sciences|July 17, 2012
Psychopathology and adversities from early- to late-adolescence: a general population follow-up study with the CBCL DSM-Oriented ScalesM Nobile, P Colombo, M Bellina, et al.
Archivio Italiano Di Urologia, Nefrologia, Andrologia : Organo Ufficiale Dell'Associazione Per La Ricerca in Urologia = Urological, Nephrological, and Andrological Sciences|June 1, 1991
[Reliability of transrectal echography in the early diagnosis of prostatic carcinoma: our experience]D Fontana, F Porpiglia, G Fasolis, et al.
European Urology|January 1, 1996
Evaluation of c-ras oncogene product (p21) in superficial bladder cancerD Fontana, M Bellina, C Scoffone, et al.
Urology|April 10, 2004
Y-neobladder: an easy, fast, and reliable procedureD Fontana, M Bellina, G Fasolis, et al.
Progress in Clinical and Biological Research|January 1, 1987
Results of long term treatment of advanced prostatic cancer with the LHRH analogue buserelinD Fontana, D F Randone, G C Isaia, et al.
Cancer|June 22, 2000
Circulating neuroendocrine markers in patients with prostate carcinomaA Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology|October 1, 1992
Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinomaD Fontana, M Bellina, L Gubetta, et al.
The Journal of Urology|September 19, 2000
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baselineA Berruti, L Dogliotti, R Bitossi, et al.
Pageof 3